tiprankstipranks
Trending News
More News >

BeiGene Ltd Grants 42,009 RSUs to Employees Under Incentive Plan

Story Highlights
BeiGene Ltd Grants 42,009 RSUs to Employees Under Incentive Plan

Confident Investing Starts Here:

The latest announcement is out from BeiGene Ltd ( (HK:6160) ).

BeiGene Ltd announced the grant of 42,009 Restricted Share Units (RSUs) to 192 employees under its 2016 Share Option and Incentive Plan. These RSUs, representing approximately 0.04% of the total issued shares, are part of the company’s strategy to incentivize and retain talent. The vesting of these RSUs is structured over a four-year period, reflecting BeiGene’s commitment to long-term employee engagement and alignment with company goals.

The most recent analyst rating on (HK:6160) stock is a Buy with a HK$148.40 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.

More about BeiGene Ltd

BeiGene Ltd is a biotechnology company that focuses on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company operates in the pharmaceutical industry and is committed to improving treatment outcomes and access for patients globally.

Average Trading Volume: 6,443,610

Technical Sentiment Signal: Buy

Current Market Cap: HK$201.2B

For detailed information about 6160 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App